Regulatory Accord, Intas, and Bio-Thera File Four IPRs Against Janssen Golimumab Patents pharminent March 27, 2026
Regulatory FDA clears Denali drug in ‘clear step’ for rare disease biotechs pharminent March 26, 2026
Regulatory FDA seeks feedback on voucher program; Study data lift ‘overhang’ on Insmed shares pharminent March 24, 2026
Regulatory Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results pharminent March 23, 2026
